Beijing Scitop Bio-Tech Co.Ltd(300858) (SZ Beijing Scitop Bio-Tech Co.Ltd(300858) , closing price: 24.7 yuan) announced on April 26 that the issues related to the issuance of shares to specific objects have been deliberated and approved at the 15th meeting of the second board of directors of the company and reviewed and approved by Shenzhen Stock Exchange. The issuance objects of shares to specific objects are no more than 35 (including) specific investors, including sun Tiansong, the controlling shareholder and actual controller of the company. The number of shares issued to specific objects this time shall be determined by dividing the total amount of raised funds by the issue price, and the number of shares issued shall not exceed 37 million shares (including this number), which shall not exceed 30% of the total share capital of the company before this issuance. The issuing price shall not be lower than 80% of the average trading price of the company’s shares 20 trading days before the pricing benchmark date. This offering is intended to raise no more than 700 million yuan.
From January to December 2020, Beijing Scitop Bio-Tech Co.Ltd(300858) of the operating revenue is composed of: food manufacturing accounts for 100.0%.
the chairman of Beijing Scitop Bio-Tech Co.Ltd(300858) is sun Tiansong, female, 55 years old, with a doctorate background; The general manager is Liu Xiaojun, male, 41 years old, with a master’s degree background.
